Description
HOSPITAL SUPPLY
First action · last action
2010-04-01 · 2010-04-01
Transactions
1
First transaction's obligation
$180,000
Base + all options value (sum of deltas)
$180,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P4742A
NAICS
621511 · MEDICAL LABORATORIES
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-04-01+$180,000= $180,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-04-01 | +$180,000 | $180,000 | HOSPITAL SUPPLY |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NH3LDK8CFAK7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N1004 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $187,594 | FY2026 |
| 36C24426N1005 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $395,322 | FY2026 |
| 36C24426N1001 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $431,969 | FY2026 |
| 36C24426N1003 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $267,954 | FY2026 |
| 36C24426N1002 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $607,544 | FY2026 |
| 36C24426N1006 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $783,641 | FY2026 |
Other recipients under 6506 from 242-NETWORK CONTRACT OFFICE 02 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| V528P1V541 | IMMUCOR INC | 242-NETWORK CONTRACT OFFICE 02 | $3,394 | FY2011 |
| V528Q1A330 | GENOMIC HEALTH, INC. | 242-NETWORK CONTRACT OFFICE 02 | $4,075 | FY2011 |
| V528P1F812 | BECTON, DICKINSON AND COMPANY | 242-NETWORK CONTRACT OFFICE 02 | $3,300 | FY2011 |
| VA528C13286 | AMERICAN NATIONAL RED CROSS, THE | 242-NETWORK CONTRACT OFFICE 02 | $167,657 | FY2011 |
| VA528C15066 | AMERICAN NATIONAL RED CROSS, THE | 242-NETWORK CONTRACT OFFICE 02 | $62,534 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA5280P3661_3600_V797P4742A_3600 · retrieved 2026-09-26.